[go: up one dir, main page]

AU2001269569A1 - Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof - Google Patents

Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof

Info

Publication number
AU2001269569A1
AU2001269569A1 AU2001269569A AU6956901A AU2001269569A1 AU 2001269569 A1 AU2001269569 A1 AU 2001269569A1 AU 2001269569 A AU2001269569 A AU 2001269569A AU 6956901 A AU6956901 A AU 6956901A AU 2001269569 A1 AU2001269569 A1 AU 2001269569A1
Authority
AU
Australia
Prior art keywords
toxoid
preparation
surface antigen
whole cell
combination vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269569A
Inventor
Cheon-Soon Bae
Hong-Joo Kim
Jong-Soo Kim
Gwan-Yeul Lim
Kyung-Nam Park
Dal-Ho Um
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Green Cross Vaccine Corp
Original Assignee
Green Cross Vaccine Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19676257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001269569(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Vaccine Corp filed Critical Green Cross Vaccine Corp
Publication of AU2001269569A1 publication Critical patent/AU2001269569A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001269569A 2000-07-05 2001-07-05 Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof Abandoned AU2001269569A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR0038164 2000-07-05
KR10-2000-0038164A KR100385711B1 (en) 2000-07-05 2000-07-05 The quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen and the preparation thereof
PCT/KR2001/001153 WO2002005846A1 (en) 2000-07-05 2001-07-05 Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen, and preparation method thereof

Publications (1)

Publication Number Publication Date
AU2001269569A1 true AU2001269569A1 (en) 2002-01-30

Family

ID=19676257

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269569A Abandoned AU2001269569A1 (en) 2000-07-05 2001-07-05 Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof

Country Status (4)

Country Link
KR (1) KR100385711B1 (en)
CN (1) CN1211121C (en)
AU (1) AU2001269569A1 (en)
WO (1) WO2002005846A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2156845A1 (en) 1992-05-23 2010-02-24 GlaxoSmithKline Biologicals SA Combined vaccines comprising hepatitis B surface antigen and other antigens
KR100385711B1 (en) * 2000-07-05 2003-05-27 녹십자백신 주식회사 The quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen and the preparation thereof
HUE034801T2 (en) * 2002-11-01 2018-02-28 Glaxosmithkline Biologicals Sa Drying process
GB0505518D0 (en) 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
PE20100365A1 (en) 2008-10-24 2010-05-21 Panacea Biotec Ltd NEW COMBINATION VACCINES WITH WHOLE CELL COUGH AND METHOD FOR THEIR PREPARATION
ES2614807T3 (en) 2010-06-04 2017-06-02 Wyeth Llc Vaccine Formulations
FR2966044B1 (en) * 2010-10-18 2012-11-02 Sanofi Pasteur METHOD FOR CONDITIONING A VACCINE CONTAINING AN ALUMINUM ADJUVANT
CN104487086B (en) * 2012-07-07 2019-08-30 巴拉特生物技术国际有限公司 Non-alcohol-free vaccine composition of animal origin and its preparation method
CN104341499B (en) * 2014-11-06 2017-05-24 遵义医学院 Preparation process of tetravalent yolk antibody preparation for resisting measles and bronchocephalitis, diphtheritis and lockjaw

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322057A1 (en) * 1973-05-02 1974-11-21 Porsche Ag DEVICE FOR CATALYTIC AFTER-BURNING OF EXHAUST GASES OF A MULTICYLINDRICAL COMBUSTION MACHINE
JP2743177B2 (en) * 1987-04-24 1998-04-22 財団法人阪大微生物病研究会 Method of culturing pertussis, pertussis toxoid and combination vaccine thereof
KR920009729A (en) * 1990-11-26 1992-06-25 전금자 Pottery manufacturing method that generates far infrared rays
AU2088992A (en) * 1992-05-05 1993-11-11 Research Foundation For Microbial Diseases Of Osaka University, The Stabilized live vaccine
EP2156845A1 (en) * 1992-05-23 2010-02-24 GlaxoSmithKline Biologicals SA Combined vaccines comprising hepatitis B surface antigen and other antigens
JPH10131967A (en) * 1996-10-25 1998-05-22 Seiko Epson Corp Bearing and motor
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition
RU2130778C1 (en) * 1998-07-31 1999-05-27 Акционерное общество закрытого типа НПК "Комбиотех Лтд" Mixed vaccine for immune prophylaxis of viral hepatitis b, tetanus, diphtheria and whooping cough
KR100385711B1 (en) * 2000-07-05 2003-05-27 녹십자백신 주식회사 The quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen and the preparation thereof

Also Published As

Publication number Publication date
CN1211121C (en) 2005-07-20
KR100385711B1 (en) 2003-05-27
KR20020005081A (en) 2002-01-17
CN1383384A (en) 2002-12-04
WO2002005846A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
SI1296715T1 (en) Multivalent vaccine composition
LU91658I2 (en) Combined diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type B conjugate vaccine (INFANRIX HEXA®)
DK1240905T5 (en) Acellular pertussis vaccine with diphtheria and tetanus toxoids
EP0914153B8 (en) Multivalent dtp-polio vaccines
HK1049106A1 (en) Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
WO1998058668A3 (en) Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae
HUP0401753A3 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
WO2001034801A3 (en) Recombinant gelatin in vaccines
WO2000056359A3 (en) Vaccine against streptococcus pneumoniae
AU4707097A (en) Multivalent vaccines
AU2001269569A1 (en) Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof
WO2001097841A3 (en) Qs-21 and il-12 as an adjuvant combination
WO1997045139A3 (en) Il-12 as an adjuvant for bordetella pertussis vaccines
WO1999037783A3 (en) Live vaccine against brucellosis
AU2001249349A1 (en) Method of doping silicon with phosphorus and growing oxide on silicon in the presence of steam
AU2002212073A1 (en) A classical swine fever virus epitope vaccine and its producing method
AU2001234616A1 (en) Vaccine composition, process and methods
WO2002032455A3 (en) Vaccine
WO2000051633A3 (en) MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE)
PL346645A1 (en) IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
WO1997046255A3 (en) Vaccine composition comprising outer membrane protein fragments of bordetella pertussis
AUPR020900A0 (en) Vaccines and methods of vaccination
WO2001004155A3 (en) Feline interleukin-12 as an immune stimulant
AU2001282503A1 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
WO2002072622A3 (en) Vaccine antigens against infection by chlamydia trachomatis